Login
$KLRS
$1.80 -$0.07 (3.74%) Close

Insider Transactions

What Kalaris Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 2
Sells 0 1
Total trades 0 7

Shares traded

3 months 12 months
Acquired 0 2,243,555
Disposed 0 68,821
Net activity +0 +2,174,734

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Akkaraju Srinivas Director May 20 Other Transaction · J +4,471 — — 19,408
Akkaraju Srinivas Director May 20 Other Transaction · J +14,937 — — 14,937
Akkaraju Srinivas Director May 20 Other Transaction · J −66,906 — — 10,657,028
Akkaraju Srinivas Director May 20 Open-market buy · P +244,300 $4.83 +$1.18M 2,224,147
Hagen Brett R Chief Accounting Officer Mar 20 Open-market sale · S −1,915 $6.72 −$12.9K 0
Akkaraju Srinivas Director Dec 22 Grant / award · A +1,500,000 $10.00 +$15M 1,500,000
Akkaraju Srinivas Director Dec 18 Open-market buy · P +479,847 $10.42 +$5M 1,979,847
Hagen Brett R Chief Accounting Officer Mar 26 Open-market sale · S −907 $8.97 −$8.14K 1,925
Feinsod Matthew Chief Medical Officer Mar 18 Grant / award · A +4,030 — — 4,030
Patel Samir Chandrakant Director Mar 18 Grant / award · A +100,800 — — 100,800
Patel Samir Chandrakant Director Mar 18 Grant / award · A +252,000 — — 252,000
Akkaraju Srinivas Director Mar 18 Grant / award · A +11,444,503 — — 11,444,503
Ferrara Napoleone Director Mar 18 Grant / award · A +504,000 — — 504,000
Hagen Brett R Chief Accounting Officer Feb 21 Open-market sale · S −96 $10.08 −$967 2,832
Miller Edward General Counsel Feb 21 Open-market sale · S −106 $10.08 −$1.07K 6,517
Sinha Vikas See Remarks Feb 21 Open-market sale · S −303 $10.08 −$3.05K 49,129
Hagen Brett R Chief Accounting Officer Jan 23 Open-market sale · S −4 $9.94 −$39.8 2,928
Hagen Brett R Chief Accounting Officer Jan 23 Open-market sale · S −32 $9.45 −$303 2,932
Miller Edward General Counsel Jan 23 Open-market sale · S −5 $9.94 −$49.7 6,623
Miller Edward General Counsel Jan 23 Open-market sale · S −47 $9.45 −$444 6,628

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support